Neglected/Tropical Disease Initiative

Neglected/Tropical Disease InitiativeLaunch program to support the diagnosis, treatment, and prevention of neglected tropical diseases. More rapid regulatory pathways and efficient approaches to clinical trials using biomarkers will hasten the development of new drugs and diagnostics for preventing and treating neglected tropical diseases. Incentives to industry will be explored to stimulate product development for many diseases with unsatisfactory diagnosis, treatment and prevention options (e.g., Chagas disease, leishmaniasis, trypanosomiasis, filariasis). ORSI leads this project in coordination with CDER, CBER, and CDRH.

A. Create neglected/tropical disease working group

3/31/2010

Completed

3/15/2010

B. Hold Part 15 public meeting

9/22/2010

Completed

9/23/2010

C. Make recommendation to the Commissioner and draft report to Congress

3/31/2011

Completed

2/28/2011

D. Promote global collaboration to coordinate ongoing/future activities

6/30/2011

Completed

6/29/2011

http://www.fda.gov/AboutFDA/Transparency/track/ucm206688.htmFDA-TRACK OC Office of the Chief Scientist Dashboard